Abstract
Premenstrual disorders are a combination of emotional, behavioral, and physical symptoms that are present in the days prior to and resolve shortly after menses. In some women, the severity of symptoms cause clinically significant distress and interfere with relationships and role functioning. This chapter discusses the definition of premenstrual disorders and how to determine the diagnosis, differential diagnoses, etiopathologic theories, and treatment options including antidepressant medications, hormonal strategies including suppression of ovulation, and nonpharmacological strategies. Both antidepressant medications and hormonal regimens can be considered first-line treatment options; treatment choice is often individually tailored to the woman’s symptoms and preferences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
O’Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman E, Halbreich U, Ismail KM, Panay N, Pearlstein T, Rapkin A, Reid R, Schmidt P, Steiner M, Studd J, Yonkers K. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13–21.
Yonkers KA, O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008;371(9619):1200–10.
Steiner M, Li T. Luteal phase and symptom-onset dosing of SSRIs/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale. CNS Drugs. 2013;27(8):583–9.
Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006;9(1):41–9.
Steiner M, Streiner DL. Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials. Can J Psychiatry. 2005;50(6):327–32.
Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;(6):CD001396.
Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol. 2008;111(5):1175–82.
Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;(2):CD006586.
Nevatte T, O’Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman EW, Halbreich U, Ismail K, Panay N, Pearlstein T, Rapkin A, Reid R, Rubinow D, Schmidt P, Steiner M, Studd J, Sundström-Poromaa I, Yonkers K. Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health. 2013;16(4):279–91.
Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM. The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysis. BJOG. 2004;111(6):585–93.
Reid RL. When should surgical treatment be considered for premenstrual dysphoric disorder? Menopause Int. 2012;18(2):77–81.
Pearlstein T. Psychotropic medications and other non-hormonal treatments for premenstrual disorders. Menopause Int. 2012;18(2):60–4.
Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health. 2006;15(1):57–69.
Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003;6(3):203–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pearlstein, T., O’Brien, S. (2017). A Woman with Inexplicable Mood Swings: Patient Management of Premenstrual Syndrome. In: Paarlberg, K., van de Wiel, H. (eds) Bio-Psycho-Social Obstetrics and Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-40404-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-40404-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40402-8
Online ISBN: 978-3-319-40404-2
eBook Packages: MedicineMedicine (R0)